A PIONEER AND LEADER LEARN MORE Contact Us Clinigma® is at the forefront of interviewing patients in clinical trials
logo
Clinigma® has a Core Team of more than 30 global researchers from various backgrounds (e.g. anthropology/sociology, data analysis, trial management, QA, IT and marketing).
The Clinigma® Core Team coordinates closely with clients, CROs and our global network of qualitative researchers ensuring a successful and secure interviewing of patients in clinical trials and strong reporting of results to clients and regulatory bodies.
logo

We are a team that consists of health economists and anthropologists with a global outreach to fit our clients’ needs. Our organization consists of more than 200 senior researchers and health economists located on all continents of the world.

Founded

in 2017

Clinigma® was founded by Jens Harald Kongsø in 2017. Jens Harald sets the strategic direction for the company, consults on qualitative projects, and maintains a dialogue with health regulators, which allows him to help shape the regulatory environment for patient-focused drug development.

Jens Harald has more than 10 years of experience in providing input to global clinical trials in a global pharmaceutical company. Here he experienced how Patient-Reported Outcomes (PROs) applied in clinical trials are insufficient as tools to provide a full picture of patients’ experiences of investigational drugs. This inspired him to pioneer the processes of interviewing patients in clinical trials. Building on the learnings, he founded the company with the aspiration of providing clarity and value to pharmaceutical companies by being their trial patients’ structured voice.

Jens Harald has organised and facilitated HEOR advisory boards and helped produce scientific advice with HTA bodies on health economics and outcomes strategies and trial programmes.

Jens Harald has published research in peer-reviewed journals and abstracts, and presented at international research conferences.

Contact Jens Harald Kongsø: [email protected]